Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations

• Published in: Journal of vascular surgery Vol. 53; no. 1; pp. 150 - 155
• Main Authors: Yang, Yaowu, Sun, Moyi, Ma, Qin, Cheng, Xiaobing, Ao, Jianhua, Tian, Lei, Wang, Lei, Lei, Delin
• Format: Journal Article
• Language: English
• Published: New York, NY Mosby, Inc 2011; Elsevier
• Subjects: Adolescent; Adult; Biological and medical sciences; Bleomycin - analogs & derivatives; Bleomycin - pharmacology; Bleomycin - therapeutic use; Child; Child, Preschool; Face - abnormalities; Female; Humans; Infant; Injections, Intralesional; Lymphatic Abnormalities - diagnostic imaging; Lymphatic Abnormalities - therapy; Magnetic Resonance Imaging; Male; Medical sciences; Middle Aged; Mouth Mucosa - abnormalities; Neck - abnormalities; Retrospective Studies; Sclerosing Solutions - pharmacology; Sclerosing Solutions - therapeutic use; Sclerotherapy - methods; Surgery; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Tongue - abnormalities; Ultrasonography, Doppler; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels; Young Adult; Bleomycin; Lymphatic malformation; Surgery; Cardiovascular disease; Congenital disease; Sclerotherapy; Lymphatic vessel disease

The purpose of this study was to document the results of bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations (LMs), and the clinical data of 65 patients between October 2004 and October 2007 were reviewed. Of the 65 patients in the study, 60 patients were given intralesional injecti...